Analysts think SLP stock price could increase by 52%
Jun 06, 2025, 11:25 AM
-36.11%
What does SLP do
Simulations Plus, based in Lancaster, California, offers modeling software and consulting services for drug discovery, employing 192 staff and providing 12 software products and various pharmacokinetic services. Their expertise spans from early drug development to regulatory submissions and includes training solutions for clinical trials.
5 analysts think SLP stock price will increase by 52.38%. The current median analyst target is $42.33 compared to a current stock price of $27.78. The lowest analysts target is $40.40 and the highest analyst target is $47.25.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
